(Q40536975)

21 September 2017

title

Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest (English)

1 reference

21 September 2017

1 reference

Jie Bai

1

1 reference

21 September 2017

Hajime Nakamura

2

1 reference

21 September 2017

Shugo Ueda

3

1 reference

21 September 2017

Yong-Won Kwon

4

1 reference

21 September 2017

Toru Tanaka

5

1 reference

21 September 2017

Sadayuki Ban

6

1 reference

21 September 2017

Junji Yodoi

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

6 July 2004

1 reference

Journal of Biological Chemistry

21 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

37

1 reference

21 September 2017

page(s)

38710-38714

1 reference

The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

High-affinity choline transport sites: use of [3H]hemicholinium-3 as a quantitative marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

The content of intracellular mitochondrial DNA is decreased by 1-methyl-4-phenylpyridinium ion (MPP+).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Cyclin ubiquitination: the destructive end of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Protein degradation or regulation: Ub the judge

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Sequence and organization of the human mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Thioredoxin expression in the human endometrium during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403329200

21 January 2018

Identifiers

DOI

10.1074/JBC.M403329200

1 reference

21 September 2017

1 reference